Healios K.K. (HLOSF)
OTCMKTS · Delayed Price · Currency is USD
3.435
+0.735 (27.22%)
At close: Jul 14, 2025
Regulus Therapeutics Market Cap
Healios K.K. has a market cap or net worth of $428.44 million as of August 5, 2025. Its market cap has increased by 344.40% in one year.
Market Cap
428.44M
Enterprise Value
409.36M
Revenue
3.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
$3.44
Market Cap Chart
Since June 16, 2015, Healios K.K.'s market cap has decreased from 543.57M to 428.44M, a decrease of -21.18%. That is a compound annual growth rate of -2.32%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 5, 2025 | 444.28M | 337.70% |
Dec 30, 2024 | 101.50M | 16.33% |
Dec 29, 2023 | 87.26M | -30.42% |
Dec 30, 2022 | 125.40M | -79.59% |
Dec 30, 2021 | 614.50M | -37.54% |
Dec 30, 2020 | 983.76M | 39.89% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo, Inc. | 1.80B |
Nika Pharmaceuticals | 972.93M |
Veradigm | 823.67M |
Tian'an Technology Group | 628.15M |
Elite Pharmaceuticals | 519.96M |
Glass House Brands | 438.99M |
American Oncology Network | 408.39M |
Northwest Biotherapeutics | 376.73M |